Elevate your local knowledge
Sign up for the iNFOnews newsletter today!
Sign up for the iNFOnews newsletter today!
Selecting your primary region ensures you get the stories that matter to you first.
BURNABY, British Columbia (AP) _ Arbutus Biopharma Corp. (ABUS) on Wednesday reported a loss of $15.9 million in its first quarter.
On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 31 cents. Losses, adjusted for stock option expense, were 19 cents per share.
The biopharmaceutical company posted revenue of $600,000 in the period.
In the final minutes of trading on Wednesday, the company’s shares hit $4.64. A year ago, they were trading at $14.61.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABUS at http://www.zacks.com/ap/ABUS
_____
Keywords: Arbutus Biopharma, Earnings Report
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Want to share your thoughts, add context, or connect with others in your community?
You must be logged in to post a comment.